发明授权
- 专利标题： Controlled release formulations
- 专利标题（中）： 控释制剂
-
申请号： US12197179申请日： 2008-08-22
-
公开(公告)号： US08329220B2公开(公告)日： 2012-12-11
- 发明人: Edward T. Maggio , Elias Meezan , Dennis J. Pillion , Sarah L. Morgan , Joe Baggott
- 申请人： Edward T. Maggio , Elias Meezan , Dennis J. Pillion , Sarah L. Morgan , Joe Baggott
- 申请人地址： US CA San Diego US AL Birmingham
- 专利权人： Aegis Therapeutics, LLC,The UAB Research Foundation
- 当前专利权人： Aegis Therapeutics, LLC,The UAB Research Foundation
- 当前专利权人地址： US CA San Diego US AL Birmingham
- 主分类号： A61K9/10
- IPC分类号： A61K9/10 ; A61K31/519 ; A61K31/12 ; A61K38/02 ; A61K31/122 ; A61K31/56 ; A61K38/22 ; A61P19/02 ; A61P25/28
摘要：
The present invention provides stable, self-assembling, biocompatible and biodegradable hydrogel formulations, into which one or more compounds may be incorporated allowing for delayed release or controlled release of the incorporated compounds as the hydrogel is degraded in the body.
公开/授权文献
- US20090110735A1 CONTROLLED RELEASE FORMULATIONS 公开/授权日：2009-04-30
信息查询
